UT Soutwestern | Strategic Alliance Partners

Latest from UT Soutwestern

Capitalizing on Cellular Therapies in Lymphoma and Myeloma

January 18, 2021

In our exclusive interview, Dr. Kansagra, Dr. D’Souza, and Dr. Dholaria provided an in-depth look into the current state of cellular therapy in hematologic malignancies, the benefits and drawbacks of approved and investigational products, and new constructs for CAR T in multiple myeloma and lymphoma.